Article Text

Download PDFPDF
Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report
  1. O P Corrigan
  1. Correspondence to:
 Dr O P Corrigan
 Centre for Family Research and Cambridge Genetics Knowledge Park, Faculty of Social and Political Sciences, University of Cambridge, Free School Lane, Cambridge, B2 3RF, UK; opc22cam.ac.uk

Abstract

In September this year the Nuffield Council on Bioethics held a meeting to disclose and discuss the main findings of their newly published report on the ethical issues associated with developments in pharmacogenetics research. The basics of pharmacogenetics science is briefly outlined, and then the extent to which the report was successful in addressing (or at least highlighting) the attendant social, ethical, and policy implications of pharmacogenetics research is evaluated.

  • ADR, adverse drug reaction
  • DNA banking
  • pharmacogenetics
  • consent
  • hype

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • The Wellcome Trust sponsored my research in this area.

  • Competing interests: none declared

Other content recommended for you